Indaptus Therapeutics
INDP
23 hedge funds and large institutions have $66.7M invested in Indaptus Therapeutics in 2018 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 5 closing their positions.
60% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 5
20% more capital invested
Capital invested by funds: $55.6M → $66.7M (+$11M)
15% more funds holding
Funds holding: 20 → 23 (+3)
17% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$609K |
| 2 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$312K |
| 3 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$255K |
| 4 |
HK
Horizon Kinetics
New York
|
+$213K |
| 5 |
Morgan Stanley
New York
|
+$198K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$1.39M |
| 2 |
Renaissance Technologies
New York
|
-$751K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$624K |
| 4 |
MIH
Meitav Investment House
Bene-Beraq,
Israel
|
-$411K |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$241K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
Millennium Management
New York
| – | -$1.39M | -121 | Closed |
|
|
DMK
27
David M. Knott
| – | -$180K | -16 | Closed |
|
|
VF
28
Virtu Financial
New York
| – | -$88K | -8 | Closed |
|
|
TI
29
Trexquant Investment
Stamford,
Connecticut
| – | -$73K | -6 | Closed |
|
30
Macquarie Group
Sydney, NSW 2000,
Australia
| – | -$8K | -1 | Closed |
|
INDP Hedge Fund Activity: Q1 2018 in Review
23 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Indaptus Therapeutics (INDP) for Q1 2018, worth a combined $66.7M — up 20% from $55.6M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new INDP positions and 5 closed out — a net gain of 3 holders — while 5 added to existing stakes and 6 trimmed.
The largest buyer was Sectoral Asset Management, adding an estimated $609K. The largest seller was Millennium Management, exiting entirely with an estimated $1.39M sold.
- 23 institutional investors held Indaptus Therapeutics (INDP) as of Q1 2018, up from 20 in Q4 2017.
- Funds reported $66.7M of Indaptus Therapeutics stock for Q1 2018, up 20% quarter-over-quarter.
- 8 funds opened new Indaptus Therapeutics positions in Q1 2018 and 5 closed out, a net change of +3 holders.
- The largest Indaptus Therapeutics buyer in Q1 2018 was Sectoral Asset Management, an estimated $609K added.
- The largest Indaptus Therapeutics seller in Q1 2018 was Millennium Management, an estimated $1.39M sold.
Based on aggregated 13F filings for Q1 2018.